Saline, Michigan
United States
53
2015-11-26
The entities that hold a legal rights for patent applications filed by inventor Wang Shaomeng:
Shaomeng Wang from Saline, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
#2 | 2015-10-22MDM2 inhibitors and therapeutic methods using the same
#3 | 2015-09-039H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors
#4 | 2014-12-25Spiro-oxindole MDM2 antagonists
#5 | 2014-09-11BET bromodomain inhibitors and therapeutic methods using the same
#6 | 2014-07-17BCL-2/BCL-XL inhibitors and therapeutic methods using the same
#7 | 2014-05-29Spiro-oxindole MDM2 antagonists
#8 | 2014-02-27Bivalent inhibitors of IAP proteins and therapeutic methods using the same
#9 | 2013-11-07Spiro-oxindole MDM2 antagonists
#10 | 2013-06-13Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#11 | 2013-01-31Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein
#12 | 2012-12-06Diazo bicyclic Smac mimetics and the uses thereof
#13 | 2012-11-29BIOMARKERS FOR GOSSYPOL CHEMOTHERAPY AND METHODS OF TREATING DISEASE
#14 | 2012-11-15Spiro-oxindole MDM2 antagonists
#15 | 2012-10-18Bivalent diazo bicyclic Smac mimetics and the uses thereof
#16 | 2012-09-13Selective ligands for the dopamine 3 (D) receptor and methods of using the same
#17 | 2012-07-26Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
#18 | 2012-05-17Spiro-oxindole MDM2 antagonists
#19 | 2012-04-26Small molecule inhibitors of MDM2 and the uses thereof
#20 | 2011-12-29STAT3 LIGANDS AND THERAPEUTIC USES THEREOF
#21 | 2011-12-22Inhibition of WDR5 interaction with its binding partners
#22 | 2011-10-13BIOMARKERS FOR MDM2 INHIBITORS FOR USE IN TREATING DISEASE
#23 | 2011-07-28Selective ligands for the dopamine 3 (D) receptor and methods of using the same
#24 | 2011-05-12Spiro-oxindole MDM2 antagonists
#25 | 2011-02-24Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof
#26 | 2010-12-16Small molecule inhibitors of MDM2 and the uses thereof
#27 | 2010-10-28Diazo bicyclic Smac mimetics and the uses thereof
#28 | 2010-10-28Small molecule inhibitors of MDM2 and the uses thereof
#29 | 2010-04-15SMAC Peptidomimetics and the Uses Thereof
#30 | 2010-03-18SMALL MOLECULE ANTAGONISTS OF BCL2 FAMILY PROTEINS
#31 | 2009-05-14Bivalent SMAC mimetics and the uses thereof
#32 | 2009-05-07APOGOSSYPOLONE AND THE USES THEREOF
#33 | 2009-04-09Small molecule antagonists of Bcl-2 family proteins
#34 | 2009-03-26GOSSYPOL CO-CRYSTALS AND THE USE THEREOF
#35 | 2009-03-26SMALL MOLECULE ANTAGONISTS OF BCL-2 FAMILY PROTEINS
#36 | 2008-10-30Conformationally constrained Smac mimetics and the uses thereof
#37 | 2008-10-09Matriptase, a serine protease and its applications
#38 | 2008-10-07Small molecule antagonists of Bcl-2 family proteins
#39 | 2008-09-23ErbB-2 selective small molecule kinase inhibitors
#40 | 2008-06-05Conformationally constrained Smac mimetics and the uses thereof
#41 | 2008-05-29Indole inhibitors of MDM2 and the uses thereof
#42 | 2008-04-17Bivalent Smac mimetics and the uses thereof
#43 | 2008-04-08Small molecule inhibitors targeted at Bcl-2
#44 | 2008-01-24Production of gossypol co-crystals
#45 | 2008-01-24Small molecule antagonists of XIAP family proteins
#46 | 2007-12-20Gossypol co-crystals and the use thereof
#47 | 2007-09-11Peptidomimetic modulators of cell adhesion
#48 | 2006-11-02Small molecule inhibitors of STAT3 and the uses thereof
#49 | 2006-11-02Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereof
#50 | 2006-09-21Small molecule inhibitors of MDM2 and the uses thereof
#51 | 2006-08-10Apogossypolone and the uses thereof
#52 | 2006-04-20Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof
#53 | 2005-10-20Gossypol co-crystals and the use thereof
69097 ⎘